NCT Number: NCT06405438
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Istanbul, 34147, Turkey (Türkiye)
Location status: Recruiting
Büşra Şirin Ahısha, MD
CONTACT
Büşra Şirin Ahısha, MD
PRINCIPAL_INVESTIGATOR
Nur Kesiktaş, MD
SUB_INVESTIGATOR
Nurdan Paker, MD
SUB_INVESTIGATOR
Selma Akkaya Arı, MD
SUB_INVESTIGATOR
Yasemin Barut, MD
SUB_INVESTIGATOR
Our study will include 60 patients aged 18-65 who visited the outpatient clinics of Beylikdüzü State Hospital between January 1, 2024, and September 1, 2024, and were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological examinations. These patients received either peloid or paraffin treatment. Patients with symptoms persisting for a minimum of 3 months will be included in the study. In this study, pain levels will be evaluated using the Visual Analog Scale (VAS), and the type and severity of symptoms will be assessed with the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). At our hospital, the standard paraffin treatment consists of 15 sessions, administered 5 days per week, while the peloid therapy consists of 10 sessions, also administered 5 days per week. The VAS, BCTQ scores, and electrophysiological evaluations of the patients will be assessed at the 4th and 12th weeks post-treatment. Electrophysiological parameters including median nerve distal motor latency (MMNDL), median nerve distal sensory latency (MNSDL), sensory nerve conduction velocity (SNCV), compound muscle action potential (CMAP), and sensory nerve action potential (SNAP) will be recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention.
Time frame: 0 day, 4th week and 12th week
The Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) consists of two parts: the Symptom Severity Scale (SSS) and the Functional Status Scale (FSS). Both parts are scored on a 5-point Likert scale, with higher scores indicating worse symptoms or functional impairment.The highest possible total score for the Symptom Severity Scale is 55, which reflects the most severe symptoms.The highest possible total score for the Functional Status Scale is 40, indicating the greatest functional impairment.The minimum total score is 19 (indicating minimal or no symptoms and functional limitations).
The maximum total score is 95 (indicating the most severe symptoms and functional limitations).
As the total score increases, the severity of symptoms and functional limitations worsens, meaning higher scores reflect worse outcomes.
Time frame: 0 day, 4th week and 12th week
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain.
The Visual Analog Scale (VAS) is a tool used to measure pain intensity. It is typically represented as a 10 cm or 100 mm line, where the patient marks their pain level.
The minimum score is 0, which indicates no pain. The maximum score is 100, indicating the worst possible pain. As the score increases, the severity of pain worsens. In this scale, higher scores reflect more intense pain levels. The Visual Analog Scale (VAS) ranges from 0 to 100 where higher scores reflect greater pain intensity.
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Contact information is provided by the study sponsor or research team.
Beylikduzu State Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06243848
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT05742776
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Afyonkarahisar, Afyonkarahi̇sar, Turkey (Türkiye)
View Trial DetailsNCT06208709
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Tucson, Arizona, United States
View Trial DetailsNCT04460521
Carpal Tunnel, Carpal Tunnel Release
Halifax, Nova Scotia, Canada
View Trial Details